ð¤: Sean Dickson on Therapeutics' Impact on Pharmaceutical Prices &
Drug Spending
 â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â
Â
View Message in Browser
<[link removed]>
[link removed]"medical services that offer little or no benefit and have potential for
harm in specific clinical scenarios."
They find that 43 percent of low-value services received by Medicare
beneficiaries originated from out-of-system clinicians, including 38
percent from specialists.
They also find that recipients of low-value care were more likely to
receive low-value medical services out of their attributed system if
they were age 75 or older, male, non-Hispanic White, rural dwelling,
more medically complex, or experiencing lower continuity of care.
Ganguli and coauthors conclude that policy leaders should make efforts
to implement low-value care reduction interventions.
Read the Article
<[link removed]' Impact on Pharmaceutical Prices & Drug
Spending
Health Affairs' Alan Weil interviews Sean Dickson from West Health
Policy Center on his recent paper examining the changes in net prices
and spending for pharmaceuticals
<[link removed]"Private Sector Solutions for Health
Equity," is sponsored by CVS Health and co-hosted by Dr. Sree Chaguturu,
Chief Medical Officer (CVS Health) and Dr. Joneigh Khaldun, Chief Health
Equity Officer (CVS Health).
The season features interviews with C-Suite level executives, such as
Karen DeSalvo (Google), Rashad Burgess (Gilead Sciences), and Thomas D.
Sequist (Massachusetts General Brigham) as they discuss private sector
initiatives and responsibility to advance health equity.
The first episode goes live next Wednesday, September 6.
Listen to the Trailer
<[link removed]'s Dueling Narratives: Protector Versus Obstacle
<[link removed]
